PURPOSE: To investigate the natural history of dot subretinal drusenoid deposits (SDD) in age-related macular degeneration, using high-resolution adaptive optics scanning laser ophthalmoscopy. METHODS: Six eyes of four patients with intermediate age-related macular degeneration were studied at baseline and 1 year later. Individual dot SDD within the central 30° retina were examined with adaptive optics scanning laser ophthalmoscopy and optical coherence tomography. RESULTS: A total of 269 solitary SDD were identified at baseline. Over 12.25 ± 1.18 months, all 35 Stage 1 SDD progressed to advanced stages. Eighteen (60%) Stage 2 lesions progressed to Stage 3 and 12 (40%) remained at Stage 2. Of 204 Stage 3 SDD, 12 (6.4%) disappeared and the rest remained. Twelve new SDD were identified, including 6 (50%) at Stage 1, 2 (16.7%) at Stage 2, and 4 (33.3%) at Stage 3. The mean percentage of the retina affected by dot SDD, measured by the adaptive optics scanning laser ophthalmoscopy, increased in 5/6 eyes (from 2.31% to 5.08% in the most changed eye) and decreased slightly in 1/6 eye (from 10.67% to 10.54%). Dynamism, the absolute value of the areas affected by new and regressed lesions, ranged from 0.7% to 9.3%. CONCLUSION: Adaptive optics scanning laser ophthalmoscopy reveals that dot SDD, like drusen, are dynamic.
PURPOSE: To investigate the natural history of dot subretinal drusenoid deposits (SDD) in age-related macular degeneration, using high-resolution adaptive optics scanning laser ophthalmoscopy. METHODS: Six eyes of four patients with intermediate age-related macular degeneration were studied at baseline and 1 year later. Individual dot SDD within the central 30° retina were examined with adaptive optics scanning laser ophthalmoscopy and optical coherence tomography. RESULTS: A total of 269 solitary SDD were identified at baseline. Over 12.25 ± 1.18 months, all 35 Stage 1 SDD progressed to advanced stages. Eighteen (60%) Stage 2 lesions progressed to Stage 3 and 12 (40%) remained at Stage 2. Of 204 Stage 3 SDD, 12 (6.4%) disappeared and the rest remained. Twelve new SDD were identified, including 6 (50%) at Stage 1, 2 (16.7%) at Stage 2, and 4 (33.3%) at Stage 3. The mean percentage of the retina affected by dot SDD, measured by the adaptive optics scanning laser ophthalmoscopy, increased in 5/6 eyes (from 2.31% to 5.08% in the most changed eye) and decreased slightly in 1/6 eye (from 10.67% to 10.54%). Dynamism, the absolute value of the areas affected by new and regressed lesions, ranged from 0.7% to 9.3%. CONCLUSION: Adaptive optics scanning laser ophthalmoscopy reveals that dot SDD, like drusen, are dynamic.
Authors: Marcela Marsiglia; Sucharita Boddu; Srilaxmi Bearelly; Luna Xu; Barry E Breaux; K Bailey Freund; Lawrence A Yannuzzi; R Theodore Smith Journal: Invest Ophthalmol Vis Sci Date: 2013-11-08 Impact factor: 4.799
Authors: Jia Qin; Nicholas Rinella; Qinqin Zhang; Hao Zhou; Jessica Wong; Michael Deiner; Austin Roorda; Travis C Porco; Ruikang K Wang; Daniel M Schwartz; Jacque L Duncan Journal: Invest Ophthalmol Vis Sci Date: 2018-12-03 Impact factor: 4.799
Authors: Yuhua Zhang; Xiaolin Wang; Srinivas R Sadda; Mark E Clark; C Douglas Witherspoon; Richard F Spaide; Cynthia Owsley; Christine A Curcio Journal: Ophthalmol Retina Date: 2019-10-31
Authors: Alessandro Rabiolo; Riccardo Sacconi; Maria Vittoria Cicinelli; Lea Querques; Francesco Bandello; Giuseppe Querques Journal: Clin Ophthalmol Date: 2017-09-20
Authors: Anna V Zarubina; Orly Gal-Or; Carrie E Huisingh; Cynthia Owsley; K Bailey Freund Journal: Invest Ophthalmol Vis Sci Date: 2017-12-01 Impact factor: 4.799
Authors: Miaoling Li; Rosa Dolz-Marco; Carrie Huisingh; Jeffrey D Messinger; Richard M Feist; Daniela Ferrara; K Bailey Freund; Christine A Curcio Journal: Retina Date: 2019-04 Impact factor: 4.256